The Overall Disability Response Score, a combination of three different assessments of disability, could be used to more accurately evaluate the effectiveness of treatments in multiple sclerosis (MS) clinical trials, a new study illustrates.
The score is composed of three measures commonly used to assess disability in MS, which evaluate hand dexterity, walking ability, and overall disability.
The study, “Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis,” was published in Multiple Sclerosis Journal. The work was funded by Biogen.
Read more at: https://multiplesclerosisnewstoday.com/news-posts/2022/09/29/study-supports-ms-disability-test-score-outcome-measure-trials/
